India TodayHealth
Could an FDA eye-stroke warning rattle India's GLP-1 boom?
A United States regulator's warning about a possible eye stroke risk is drawing attention to India's fast-growing market for weight-loss and diabetes medicines. The brief report gives no details on affected drugs or any response from Indian authorities.
This card is an AI-assisted summary of reporting published by India Today. Read the original report before relying on it for medical, legal, financial, safety, or emergency decisions.